GlassScriptPhysician profile
Aaron Richardson
NPI 1902291107
$50,849.73
in general payments reported to CMS, 2019-2025
24 companies · $965 in 2025
The $965 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20K · 2022: $27K · 2023: $2,171 · 2024: $800 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,536 · Travel and Lodging: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,536.09 |
| Travel and Lodging | $399.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $45,529.63 | 2021-2025 | Micra, Na, Artic-L 3d Ti Spinal System With Tionic Technology |
| Philips North America LLC | $3,427.99 | 2022 | |
| Abbott Laboratories | $535.48 | 2023-2025 | Ensite Precision, Aveir, Ensite |
| Biosense Webster, INC. | $239.34 | 2023-2024 | Qdot Micro Catheter, Carto 3 |
| Merck Sharp & Dohme LLC | $217.81 | 2024-2025 | Winrevair, Verquvo |
| Boston Scientific Corporation | $195.81 | 2023-2025 | Resonate El Icd Vr, Bodyguardian, Watchman Access System |
| Cardiva Medical, INC. | $144.79 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Pfizer INC. | $102.28 | 2024-2025 | |
| Novo Nordisk INC | $60.83 | 2023-2024 | Ozempic, Rybelsus |
| Cvrx, INC. | $46.50 | 2024-2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $45.20 | 2024 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.16 | 2023-2024 | Lifevest |
| Phathom Pharmaceuticals, INC. | $36.86 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.82 | 2024 | Jardiance |
| Edwards Lifesciences Corporation | $29.29 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $25.11 | 2024 | Nexletol |
| Becton, Dickinson and Company | $22.20 | 2023 | Venovo |
| W. L. Gore & Associates, INC. | $21.82 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Bayer Healthcare Pharmaceuticals INC. | $20.70 | 2025 | |
| Baxter Healthcare | $20.15 | 2025 | |
| Hydrofera LLC | $16.30 | 2025 | Hydrofera Blue |
| Janssen Pharmaceuticals, INC | $14.51 | 2023 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $13.79 | 2024 | Arcalyst |
| Cordis US Corp. | $13.36 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.